Geoff Macintyre

Title: Geoff Macintyre: Innovator in Cancer Treatment Prediction

Introduction

Geoff Macintyre is a notable inventor based in London, GB. He has made significant contributions to the field of cancer treatment through his innovative methods for predicting treatment responses in cancer patients. His work is crucial in enhancing the effectiveness of cancer therapies.

Latest Patents

Geoff Macintyre holds a patent titled "Methods for predicting treatment response in cancers." This invention provides methods for predicting the treatment response of a cancer patient by utilizing a tumor copy number profile. The method involves analyzing the copy number profile to determine whether the characteristics of at least one copy number feature indicate the presence of focal amplifications in the tumor genome. Specifically, it assesses features such as copy number change-point, segment size, and segment copy number. The invention predicts that a patient is likely to be resistant to treatment with agents that induce the formation of micronuclei, such as doxorubicin, if the characteristics of the copy number features suggest focal amplifications in the tumor genome. Additionally, related methods and systems are provided.

Career Highlights

Geoff Macintyre is associated with Cancer Research Technology Limited, where he applies his expertise in cancer research and treatment. His innovative approach has the potential to significantly impact patient outcomes in cancer therapy.

Collaborations

Geoff has collaborated with notable colleagues, including James Brenton and Anna Piskorz. Their combined efforts contribute to advancing cancer research and improving treatment methodologies.

Conclusion

Geoff Macintyre's work in predicting treatment responses in cancer patients exemplifies the importance of innovation in medical research. His contributions are vital for developing more effective cancer therapies and improving patient care.